Johnson & Johnson Family of Companies
NEWS
Pfizer announced plans to create a professional services office in Tampa, Florida. It will be located in more than 100,000 square feet of office space and believe they will be generating hundreds of new jobs.
A manufacturing mistake at Emergent Biosolutions ruined a 15 million-dose batch of Johnson & Johnson’s Vaxzevria in production.
As biopharma companies focus on efficiencies and close sites, jobs are getting lost. Here’s a look.
This morning, Janssen announced Ponvory has been greenlit as the only oral disease-modifying therapy studied against an established oral comparator for this indication.
Long-term data from Janssen’s Phase III DISCOVER-2a trial show that TREMFYA® (guselkumab), a selective IL-23 inhibitor, lead to skin clearance and joint symptom relief for up to two years in patients with active psoriatic arthritis.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for March 2, 2021.
The company has agreed to deliver 100 million doses of the vaccines by the end of June.
The date set by the FDA’s independent advisors for debating that decision is Friday, February 26.
There’s plenty of COVID-19-related news today. Here’s a look.
JOBS
IN THE PRESS